Varenicline Tartrate
Brands: Chantix · Varenicline · Varenicline Tartrate
21 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 27 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Chantix · Varenicline · Varenicline Tartrate
Average across 27 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Kanchan Healthcare Inc | unknown | 3 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 3 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 3 | SUPPLYING |
| A-S Medication Solutions | repackager | 3 | SUPPLYING |
| Leading Pharma, LLC | unknown | 3 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 3 | SUPPLYING |
| Indoco Remedies Limited | unknown | 3 | SUPPLYING |
| Micro Labs Limited | generic | 3 | SUPPLYING |
| Pfizer Laboratories Div Pfizer Inc | unknown | 3 | SUPPLYING |
| Florida Pharmaceutical Products, LLC | unknown | 2 | SUPPLYING |
| AvKARE | relabeler | 2 | SUPPLYING |
| Par Health USA, LLC | unknown | 2 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 2 | SUPPLYING |
| Marlex Pharmaceuticals Inc | unknown | 2 | SUPPLYING |
+ 6 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit — Recalling firm: Pfizer Inc. — Nationwide
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit — Recalling firm: Pfizer Inc. — Nationwide
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit — Recalling firm: Pfizer Inc. — Nationwide
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit — Recalling firm: Pfizer Inc. — Nationwide
CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit — Recalling firm: Pfizer Inc. — Nationwide
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC